Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results
Tenon Medical, Inc. (NASDAQ: TNON) had its price target lowered by analysts at Benchmark Co. from $5.00 to $3.00. They now have a "speculative buy" rating on the stock.
Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors [Yahoo! Finance]
Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System [Yahoo! Finance]